204 related articles for article (PubMed ID: 1660142)
21. [Reversal of drug resistance in human cancer cells by anti-oncogenes].
Funato T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):395-400. PubMed ID: 9063474
[TBL] [Abstract][Full Text] [Related]
22. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme.
Kobayashi H; Dorai T; Holland JF; Ohnuma T
Cancer Res; 1994 Mar; 54(5):1271-5. PubMed ID: 8118816
[TBL] [Abstract][Full Text] [Related]
23. Ribozyme-mediated modulation of human O6-methylguanine-DNA methyltransferase expression.
Potter PM; Harris LC; Remack JS; Edwards CC; Brent TP
Cancer Res; 1993 Apr; 53(8):1731-4. PubMed ID: 8467487
[TBL] [Abstract][Full Text] [Related]
24. A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells.
Jiang WG; Grimshaw D; Lane J; Martin TA; Abounader R; Laterra J; Mansel RE
Clin Cancer Res; 2001 Aug; 7(8):2555-62. PubMed ID: 11489839
[TBL] [Abstract][Full Text] [Related]
25. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
Hatanaka H; Abe Y; Naruke M; Asai S; Miyachi H; Kawakami T; Nagata J; Kamochi J; Kijima H; Yamazaki H; Scanlon KJ; Ueyama Y; Nakamura M
Anticancer Res; 2001; 21(2A):879-85. PubMed ID: 11396179
[TBL] [Abstract][Full Text] [Related]
26. Influence of the proto-oncogene c-fos on cisplatin sensitivity.
Moorehead RA; Singh G
Biochem Pharmacol; 2000 Feb; 59(4):337-45. PubMed ID: 10644041
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme.
Ojwang JO; Hampel A; Looney DJ; Wong-Staal F; Rappaport J
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10802-6. PubMed ID: 1438280
[TBL] [Abstract][Full Text] [Related]
28. Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme.
Holm PS; Scanlon KJ; Dietel M
Br J Cancer; 1994 Aug; 70(2):239-43. PubMed ID: 7914421
[TBL] [Abstract][Full Text] [Related]
29. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
He Y; Zhang J; Zhang J; Yuan Y
Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085
[TBL] [Abstract][Full Text] [Related]
30. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
Sun LQ; Wang L; Gerlach WL; Symonds G
Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
[TBL] [Abstract][Full Text] [Related]
31. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
Phylactou LA; Tsipouras P; Kilpatrick MW
Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
[TBL] [Abstract][Full Text] [Related]
32. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
J Neurosurg; 2000 Feb; 92(2):297-305. PubMed ID: 10659018
[TBL] [Abstract][Full Text] [Related]
33. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
Kowalski P; Stein U; Scheffer GL; Lage H
Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458
[TBL] [Abstract][Full Text] [Related]
34. Hairpin ribozyme specificity in vivo: a case of promiscuous cleavage.
Denman RB
Biochem Biophys Res Commun; 1999 Apr; 257(2):356-60. PubMed ID: 10198217
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the participation of topoisomerases I and II in cadmium-induced metallothionein expression in Chinese hamster ovary cells.
Mattern MR; Tan KB; Zimmerman JP; Mong SM; Bartus JO; Hofmann GA; Drake FH; Johnson RK; Crooke ST; Mirabelli CK
Anticancer Drug Des; 1989 Aug; 4(2):107-24. PubMed ID: 2478139
[TBL] [Abstract][Full Text] [Related]
36. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis.
Orlandi L; Binda M; Folini M; Bearzatto A; Villa R; Daidone MG; Zaffaroni N
Prostate; 2003 Feb; 54(2):133-43. PubMed ID: 12497586
[TBL] [Abstract][Full Text] [Related]
37. Screening for important base identities in the hairpin ribozyme by in vitro selection for cleavage.
Siwkowski A; Humphrey M; De-Young MB; Hampel A
Biotechniques; 1998 Feb; 24(2):278-84. PubMed ID: 9494730
[TBL] [Abstract][Full Text] [Related]
38. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
Abdel-Mageed A; Agrawal KC
Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of fatty acid synthesis by expression of an acetyl-CoA carboxylase-specific ribozyme gene.
Ha J; Kim KH
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9951-5. PubMed ID: 7937924
[TBL] [Abstract][Full Text] [Related]
40. A new type of hairpin ribozyme consisting of three domains.
Komatsu Y; Kanzaki I; Shirai M; Ohtsuka E
Biochemistry; 1997 Aug; 36(32):9935-40. PubMed ID: 9245427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
